Biodesix Common Stock Total Equity from 2010 to 2025

BDSX Stock  USD 0.67  0.04  5.63%   
Biodesix Common Stock Total Equity yearly trend continues to be fairly stable with very little volatility. Common Stock Total Equity is likely to outpace its year average in 2025. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
2010-12-31
Previous Quarter
31.1 K
Current Value
32.6 K
Quarterly Volatility
13.9 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biodesix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodesix's main balance sheet or income statement drivers, such as Interest Income of 25.9 K, Depreciation And Amortization of 3.2 M or Interest Expense of 6.9 M, as well as many indicators such as Price To Sales Ratio of 2.64, Dividend Yield of 0.0 or PTB Ratio of 7.36. Biodesix financial statements analysis is a perfect complement when working with Biodesix Valuation or Volatility modules.
  
Check out the analysis of Biodesix Correlation against competitors.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Latest Biodesix's Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of Biodesix over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Biodesix's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biodesix's overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Slightly volatile
   Common Stock Total Equity   
       Timeline  

Biodesix Common Stock Total Equity Regression Statistics

Arithmetic Mean11,353
Geometric Mean3,513
Coefficient Of Variation122.27
Mean Deviation12,942
Median1,000.00
Standard Deviation13,882
Sample Variance192.7M
Range31.6K
R-Value0.86
Mean Square Error55.3M
R-Squared0.73
Significance0.000024
Slope2,495
Total Sum of Squares2.9B

Biodesix Common Stock Total Equity History

202532.6 K
202431.1 K
202027 K

About Biodesix Financial Statements

Biodesix investors use historical fundamental indicators, such as Biodesix's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodesix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Total Equity31.1 K32.6 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.